Skip to content

Acceleron reaffirmed as buy by FBR

April 15, 2017

FBR & Co reaffirmed their buy rating on shares of Acceleron Pharma Inc (NASDAQ:XLRN) in a research report sent to investors on Sunday.

http://bit.ly/2pCfR93

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: